Imperva Inc. (IMPV) SVP Sells $284,682.00 in Stock
Imperva Inc. (NYSE:IMPV) SVP Mark E. Kraynak sold 5,582 shares of the stock in a transaction that occurred on Friday, September 23rd. The stock was sold at an average price of $51.00, for a total value of $284,682.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Imperva Inc. (NYSE:IMPV) opened at 52.72 on Friday. The firm’s market cap is $1.72 billion. The firm’s 50 day moving average price is $46.79 and its 200-day moving average price is $44.45. Imperva Inc. has a 52 week low of $31.11 and a 52 week high of $77.99.
Imperva (NYSE:IMPV) last issued its quarterly earnings data on Thursday, August 4th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.04) by $0.19. The business earned $57.87 million during the quarter, compared to the consensus estimate of $66.06 million. Imperva had a negative return on equity of 25.68% and a negative net margin of 23.75%. The company’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.08) earnings per share. On average, analysts forecast that Imperva Inc. will post ($0.80) EPS for the current year.
IMPV has been the subject of a number of recent research reports. Pacific Crest cut Imperva from an “overweight” rating to a “sector weight” rating and decreased their price objective for the stock from $47.00 to $30.00 in a research report on Tuesday, August 30th. JPMorgan Chase & Co. reissued a “hold” rating on shares of Imperva in a report on Tuesday, July 12th. Nomura reissued a “buy” rating and issued a $55.00 price target (down from $60.00) on shares of Imperva in a report on Friday, July 15th. Imperial Capital reissued an “outperform” rating and issued a $50.00 price target (down from $55.00) on shares of Imperva in a report on Monday, August 8th. Finally, Morgan Stanley set a $35.00 price target on Imperva and gave the company a “sell” rating in a report on Friday, August 5th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and thirteen have issued a buy rating to the stock. Imperva has an average rating of “Buy” and an average price target of $53.33.
A number of large investors have recently modified their holdings of the company. Raymond James & Associates boosted its stake in shares of Imperva by 3.2% in the second quarter. Raymond James & Associates now owns 6,421 shares of the company’s stock worth $276,000 after buying an additional 197 shares in the last quarter. State Board of Administration of Florida Retirement System boosted its stake in shares of Imperva by 1.6% in the second quarter. State Board of Administration of Florida Retirement System now owns 17,640 shares of the company’s stock worth $759,000 after buying an additional 277 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in shares of Imperva by 0.3% in the second quarter. Ameriprise Financial Inc. now owns 106,652 shares of the company’s stock worth $4,587,000 after buying an additional 290 shares in the last quarter. Zacks Investment Management boosted its stake in shares of Imperva by 1.8% in the second quarter. Zacks Investment Management now owns 22,093 shares of the company’s stock worth $950,000 after buying an additional 390 shares in the last quarter. Finally, Teacher Retirement System of Texas boosted its stake in shares of Imperva by 13.7% in the second quarter. Teacher Retirement System of Texas now owns 3,975 shares of the company’s stock worth $171,000 after buying an additional 478 shares in the last quarter. Hedge funds and other institutional investors own 93.26% of the company’s stock.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company operates in the segment of development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises.
Receive News & Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related companies with MarketBeat.com's FREE daily email newsletter.